# US 2019/0054468 A1 · Devices, systems and methods for sample detection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0054468 A1
- Document ID: US20190054468A1
- Status: Published application
- Kind: A1
- Application number: 15/770,413
- Filed: 2016-10-21
- Published: 2019-02-21
- Earliest claimed: 2015-10-23
- Assignees: University of Virginia Patent Foundation
- Applicants: University of Virginia Patent Foundation
- Inventors: James P. LANDERS; Kimberly Renee JACKSON; Daniel MILLS; Gavin T. GARNER; Jacquelyn A. DuVall; Jingyi LI
- Web page: https://patentgrep.com/patent/US20190054468A1

## CPC

- B01L 3/502738: {characterised by integrated valves (throttle valves in microfluidic sample containers B01L3/502746)}
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/6858: Allele-specific amplification
- G01N 33/52: Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)}
- G01N 33/54326: {Magnetic particles}
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- G01N 35/00069: {whereby the sample substrate is of the bio-disk type, i.e. having the format of an optical disk}
- B01L 2200/0647: Handling flowable solids, e.g. microscopic beads, cells, particles
- B01L 2300/0803: Disc shape
- B01L 2300/0867: Multiple inlets and one sample wells, e.g. mixing, dilution
- B01L 2400/0409: centrifugal forces
- B01L 2400/043: magnetic forces
- B01L 2400/0633: with moving parts
- B01L 2400/0638: membrane valves, flap valves
- C12Q 2563/143: Magnetism, e.g. magnetic label
- C12Q 2563/149: Particles, e.g. beads
- C12Q 2565/113: based on agglutination/precipitation
- G01N 35/0098: {involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation (magnetic particles used in immunoassays G01N33/54326; magnetic separation in general B03C)}
- H04N 2201/0081: Image reader (H04N2201/0091 - H04N2201/0094 take precedence)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H04N: PICTORIAL COMMUNICATION, e.g. TELEVISION

## Abstract

This disclosure provides for apparatuses, systems and methods for in vitro sample detection. For example in one embodiment, this disclosure provides an automated Pe-toner microfluidic device (and related method) on a centrifugal platform for DNA sample lysis and DNA extraction. A second embodiment provides a system and method for qualitative detection, quantification, and real-time monitoring of nucleic acid amplification products using magnetic bead aggregation inhibition. A third embodiment provides a platform for simultaneous detection of mRNA markers from blood, cell-free semen, sperm, saliva, and vaginal fluid. The third embodiment comprises a system and method that provide for simple, rapid, and fluorescence-free detection of body fluids using mRNA marker amplification and optical detection for mRNA marker analysis with a smart phone with image analysis.

## Claims

### Claim 1

A method to detect a target sequence in a sample, comprising:
providing one or more aliquots of an amplification reaction specific for amplifying the target sequence in a sample;
contacting the aliquot, magnetic beads and an amount of isolated nucleic acid of greater than about 5 kb in length, optionally under chaotropic conditions, thereby providing a mixture;
subjecting the mixture to conditions that allow for aggregation of the beads, wherein the absence of aggregation under the conditions is indicative of the presence of amplified target sequence; and
detecting the presence or amount of aggregation.

### Claim 2 (depends on 1)

The method of claim 1 wherein the target sequence is from a pathogen.

### Claim 3 (depends on 2)

The method of claim 2 wherein the pathogen is a bacterium, virus or parasite.

### Claim 4 (depends on 1)

The method of claim 1 wherein the isolated nucleic acid is greater than about 10 kb in length.

### Claim 5 (depends on 1)

The method of claim 1 wherein the conditions to allow aggregation are a rotating magnetic field, acoustic energy or vibration.

### Claim 6 (depends on 1)

The method of claim 1 wherein the aliquot is contacted with the beads before contact with the isolated nucleic acid.

### Claim 7 (depends on 1)

The method of claim 1 wherein the aggregation is not sequence-specific.

### Claim 8 (depends on 1)

The method of claim 1 wherein the magnetic beads are coated with silica.

### Claim 9 (depends on 1)

The method of claim 1 wherein the amount of aggregation is monitored over time for the amplification reaction.

### Claim 10 (depends on 1)

The method of claim 1 wherein the sample is a blood sample, urine sample, plasma or serum sample, nasal swab sample, or a cerebrospinal fluid sample.

### Claim 11 (depends on 1)

The method of claim 1 wherein the sample comprises cells.

### Claim 12 (depends on 11)

The method of claim 11 wherein the sample comprises human cells.

### Claim 13 (depends on 1)

The method of claim 1 wherein the sample is a tissue biopsy.

### Claim 14 (depends on 1)

The method of claim 1 wherein aggregation is detected using a system that contains a camera and optionally analyzes images from the camera.

### Claim 15 (depends on 14)

The method of claim 14 wherein the system comprises a cell phone.

### Claim 16 (depends on 1)

The method of claim 1 wherein the amplification reaction is a loop mediated isothermal amplification reaction.

### Claim 17 (depends on 1)

The method of claim 1 wherein the amplification reaction is on a chip.

### Claim 18 (depends on 1)

The method of claim 1 wherein the beads and the isolated nucleic acid are added to the chip.

### Claim 19 (depends on 1)

The method of claim 1 wherein the isolated nucleic acid comprises genomic DNA.

### Claim 20 (depends on 19)

The method of claim 19 wherein the isolated nucleic acid is human genomic DNA.

### Claim at position 21

-51. (canceled)
